BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17622469)

  • 21. [Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice].
    Jia CR; Yang SY; Han SY; Sun L
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2204-8. PubMed ID: 19080673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF blockade decelerates the growth of a murine experimental osteosarcoma.
    Yin D; Jia T; Gong W; Yu H; Wooley PH; Mott MP; Yang SY
    Int J Oncol; 2008 Aug; 33(2):253-9. PubMed ID: 18636145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soluble Flt-1 gene delivery in acute myeloid leukemic cells mediating a nonviral gene carrier.
    Amini R; Azizi Jalilian F; Veerakumarasivam A; Abdullah S; Abdulamir AS; Nadali F; Rosli R
    Biomed Res Int; 2013; 2013():752603. PubMed ID: 23509773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Construction and expression of soluble vascular endothelial growth factor receptor-1 eukaryotic expression vector and its effect on proliferation of vascular endothelial cells].
    Ji L; Mao S; Liu H; Xu S; Yang Y; Yi C; Huang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Apr; 27(2):369-72. PubMed ID: 20481321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulation of soluble vascular endothelial growth factor receptor type 1 by endogenous prostacyclin inhibitor coupling factor 6 in vascular endothelial cells: a role of acidosis-induced c-Src activation.
    Echizen T; Osanai T; Ashitate T; Yokoyama H; Shibutani S; Tanaka M; Tomita H; Magota K; Okumura K
    Hypertens Res; 2009 Mar; 32(3):182-7. PubMed ID: 19262480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Antagonism of Vascular Endothelial Growth Factor Reduces Mortality of Mice with Acute Respiratory Distress Syndrome.
    Zhang Z; Lu DS; Zhang DQ; Wang X; Ming Y; Wu ZY
    Curr Med Sci; 2020 Aug; 40(4):671-676. PubMed ID: 32862377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo.
    Ramachandra S; D'Souza SS; Gururaj AE; Shaila MS; Salimath BP
    J Gene Med; 2009 May; 11(5):422-34. PubMed ID: 19266483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor and soluble FLT-1 receptor interactions and biological implications.
    Malecki M; Trembacz H; Szaniawska B; Przybyszewska M; Janik P
    Oncol Rep; 2005 Dec; 14(6):1565-9. PubMed ID: 16273257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-(1-7) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1.
    Krishnan B; Torti FM; Gallagher PE; Tallant EA
    Prostate; 2013 Jan; 73(1):60-70. PubMed ID: 22644934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque.
    Wang Y; Zhou Y; He L; Hong K; Su H; Wu Y; Wu Q; Han M; Cheng X
    Clin Exp Med; 2011 Jun; 11(2):113-21. PubMed ID: 20821246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
    Song Y; Shen K; Yu JR
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
    Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice.
    Zhu H; Li Z; Mao S; Ma B; Zhou S; Deng L; Liu T; Cui D; Zhao Y; He J; Yi C; Huang Y
    Cancer Gene Ther; 2011 Dec; 18(12):884-96. PubMed ID: 21921942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Retros Flt-1 decelerates the growth of a murine experimental osteosarcoma].
    Xin XT; Yin DZ; Lan H; Chen C; Liu B; Yang SY
    Zhonghua Wai Ke Za Zhi; 2011 Aug; 49(8):746-51. PubMed ID: 22168943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor microenvironment modifications induced by soluble VEGF receptor expression in a rat liver metastasis model.
    Bertin S; Mohsen-Kanson T; Baqué P; Gavelli A; Momier D; Anjuere F; Carle GF; Pierrefite-Carle V
    Cancer Lett; 2010 Dec; 298(2):264-72. PubMed ID: 20702033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. sFLT-1 inhibits proliferation, migration, and invasion of colorectal cancer SW480 cells through vascular mimicry formation suppression.
    Jinjun W; Zhaowei W; Qiang L; Zhijun X; Juanzi Z; Lin L; Guixi J
    Tumour Biol; 2017 May; 39(5):1010428317698339. PubMed ID: 28468595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.